[Reuters/CNBC.com] Genetic testing company 23andMe on Tuesday won U.S. Food and Drug Administration approval to sell genetic tests for three key breast cancer mutations directly to consumers, a coup for the company that has been gradually winning approval for such tests after FDA banned its Personal Genome Service in 2013... Click here to read.(Photo: Lab/Creative Commons/via Pixabay)

Search the Articles Archives

To Order by Phone Call: 1-866-354-5245 (1-541-926-3250 outside the U.S.)

Steve Shultz, Managing Editor

Aimee Herd, Editor

Teresa Neumann, Reporter

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2017. All Rights Reserved.

Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.